Clinical Trials Directory

Trials / Completed

CompletedNCT05007249

Benefit of the Chalaxie Pedagogical Tool in the Management of Overweight or Obese Children With Intellectual Disability : a Pilot Monocentric Prospective Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace · Academic / Other
Sex
All
Age
11 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to determine the benefit of the Chalaxie pedagogical evaluation tool in the management of overweight or obese children with intellectual disability. Chalaxie is a software developped as a pedagogical evaluation tool. It is used in the therapeutic education of overweight and obese children and allow the clinican to explore several skills of the child, such as self-esteem.

Detailed description

Secondary objectives 1. To assess the feasibility of the Chalaxie tool use during a medical visit; 2. To assess the relevance of the Chalaxie tool for the pediatrician; 3. To describe the characteristics of the patients followed at the "Réseau ODE"; 4. To evaluate patient self-esteem. Conduct of research After receiving written consent from the study participant and parental authority, the patients will have two visits with the pediatrician during which they will use the Chalaxie pedagogical evaluation tool. At the first visit, they will use the self-esteem assessment module. At the second visit (i.e. final visit), which should take place between 3 weeks and 2 months after the first visit, they will use a module of their choice.

Conditions

Interventions

TypeNameDescription
PROCEDUREUse of the Chalaxie pedagogical evaluation toolUse of the Chalaxie pedagogical evaluation tool during two visits

Timeline

Start date
2021-07-28
Primary completion
2022-02-17
Completion
2022-02-17
First posted
2021-08-16
Last updated
2022-06-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05007249. Inclusion in this directory is not an endorsement.